274 related articles for article (PubMed ID: 7595718)
1. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage.
Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I
J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718
[TBL] [Abstract][Full Text] [Related]
2. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
4. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
5. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
Davis R; Yarker YE; Goa KL
Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
[TBL] [Abstract][Full Text] [Related]
6. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
Ehsanullah RS; Page MC; Tildesley G; Wood JR
BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
[TBL] [Abstract][Full Text] [Related]
7. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
8. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
Delmas PD; Lambert R; Capron MH
Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
[TBL] [Abstract][Full Text] [Related]
9. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
[TBL] [Abstract][Full Text] [Related]
10. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
[TBL] [Abstract][Full Text] [Related]
11. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
12. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
[TBL] [Abstract][Full Text] [Related]
13. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
Graham DY; White RH; Moreland LW; Schubert TT; Katz R; Jaszewski R; Tindall E; Triadafilopoulos G; Stromatt SC; Teoh LS
Ann Intern Med; 1993 Aug; 119(4):257-62. PubMed ID: 8328732
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
[TBL] [Abstract][Full Text] [Related]
15. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
[TBL] [Abstract][Full Text] [Related]
16. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
[TBL] [Abstract][Full Text] [Related]
17. Prevention of NSAID-induced gastroduodenal ulcers.
Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
[TBL] [Abstract][Full Text] [Related]
18. Misoprostol and NSAID ulcers.
Isaacs P
Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
[No Abstract] [Full Text] [Related]
19. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
Sartori S; Trevisani L; Nielsen I; Tassinari D; Panzini I; Abbasciano V
J Clin Oncol; 2000 Feb; 18(3):463-7. PubMed ID: 10653861
[TBL] [Abstract][Full Text] [Related]
20. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
Koch M; Dezi A; Ferrario F; Capurso I
Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
